• Genetics:
o AD inheritance; mutations in PKD1 (85%) or PKD2 (15%)
o PKD1 associated with earlier onset and faster progression to ESRD
• Clinical Features:
o Bilateral renal cysts (from cortex and medulla) → progressive renal enlargement and CKD
o Hypertension (often early finding)
o Haematuria, flank pain, recurrent UTIs or nephrolithiasis
o Berry aneurysms → risk of subarachnoid haemorrhage (screen if FHx)
o Hepatic cysts (common), also pancreatic/splenic cysts
o Mitral valve prolapse, aortic root dilatation
• Diagnosis:
o Renal USS: ≥3 cysts bilaterally in age >40 is diagnostic with +FHx
o MRI for detailed assessment or screening relatives
• Management:
o Blood pressure control: ACEi/ARB preferred
o Tolvaptan (vasopressin V2 antagonist): slows cyst growth and CKD progression in selected patients
o Monitor for complications (e.g. haematuria, infection, ESRD)
o Dialysis/transplant if ESRD develops
• Genetics:
o X-linked (most common), also autosomal dominant/recessive variants
o Defect in type IV collagen
• Clinical Features:
o Persistent microscopic haematuria ± proteinuria
o Progresses to CKD/ESRD in adolescence/young adulthood
o Sensorineural deafness (bilateral, progressive)
o Ocular abnormalities: anterior lenticonus, retinal flecks
o Family history of haematuria and deafness often present
• Diagnosis:
o Electron microscopy: basket-weave appearance of GBM
o Genetic testing may confirm diagnosis
• Management:
o ACE inhibitors to slow progression
o Regular monitoring of renal function and hearing
o Consider transplant in ESRD
• Cause: Thinning of glomerular basement membrane; often familial
• Clinical Features:
o Isolated microscopic haematuria
o Normal renal function; no proteinuria or hypertension
o Excellent long-term prognosis
• Diagnosis:
o EM: thinned GBM
o Often diagnosed after exclusion of other causes
• Management:
o Reassurance; no treatment needed
• Cause: Congenital dilation of collecting ducts in renal medulla
• Clinical Features:
o Often asymptomatic and discovered incidentally on imaging
o May present with nephrocalcinosis, haematuria, recurrent UTIs or stones
• Diagnosis:
o CT or IVU: characteristic ‘brush-like’ appearance in renal medulla
• Management:
o Conservative; hydration to reduce stone risk
o Treat complications (e.g. stones, infection)
• Genetics:
o X-linked lysosomal storage disorder
o Deficiency of α-galactosidase A → accumulation of globotriaosylceramide
• Renal Features:
o Proteinuria, progressive CKD
o May resemble FSGS histologically
• Extra-renal Features:
o Peripheral neuropathy (burning pain)
o Angiokeratomas, hypohidrosis
o Corneal verticillata, cardiac hypertrophy, stroke in young
• Diagnosis:
o α-gal A activity (low in males), genetic testing
o Renal biopsy if diagnosis unclear
• Management:
o Enzyme replacement therapy
o Supportive care (ACEi for proteinuria, pain management)
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.